leisure time -WSS

leisure time

author：leisure time 2025-09-07 11:13:15 - browse：92

Duchenne muscular dystrophy is a devastating disease and, until very recently, was one without much hope. When Hawken Miller was diagnosed at age 5, the physician told his parents to enjoy the time they had with him, as there wouldn’t be much. Over 20 years later, Miller is a journalist and content strategist for CureDuchenne, an organization started by his mother when he was diagnosed, and new treatment is on the horizon.

Last month, the FDA approved a new gene therapy from Sarepta Therapeutics that will provide hope for many patients and families. The new drug, however, has its limitations — it’s only approved for children age 4-5, for example. Miller joined the podcast to discuss how this drug may change lives, what more needs to happen, and what his personal experience has been living with Duchenne.

“For the older boys, we’re running up against the clock a little bit with what we’re able to do and what we’re not able to do,” Miller said. “And if we’re able to try anything that could possibly help, I think most people would like the opportunity to do that.”

The conversation is based off his recent First Opinion, “The FDA’s approval of a new gene therapy for Duchenne muscular dystrophy won’t help me — but it gives me hope.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： An Ebola outbreak presents a new mystery involving children

WSS

Choosing scientific sides in the fight against Alzheimer's

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

Albert Bourla of Pfizer: worst biopharma CEO of 2023

What STAT readers think about the FDA and patient advocacy

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Bristol Myers buys into radiopharmaceuticals with RayzeBio

explore

leisure time

focus

Anesthesiologist group: stop taking Ozempic before surgery

Keeping primary care docs in field isn't impossible, says AAFP CEO

Guidelines to prevent youth baseball injuries need more muscle

Lessons Learned: This is why you network to find that industry job you want

Drug repurposing or repositioning? The language matters

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Trump demands the U.S. pay no more for drugs than other countries … again

What STAT readers think about the FDA and patient advocacy

Medicare details structure of new drug price negotiation program

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

explore

Christmas in the PICU brings some surprising joy

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Why health records don't always know when patients are dead

Carvykti CAR

The painfully weak evidence on taking collagen to treat arthritis

hotspot

hotspot

entertainment

focus